Video

Experts Highlight Anticipated Research to Be Revealed at ESMO 2019

Author(s):

OncLive Staff
Conference|ESMO Congress

OncLive interviewed experts at the State of the Science Summits™ in September 2019 on anticipated research to be presented at the 2019 ESMO Congress.

OncLive interviewed experts at the State of the Science Summits™ in September 2019 on anticipated research to be presented at the 2019 ESMO Congress.

Related Videos
John Burke, MD
Justin M. Watts, MD
Rohan Garje, MD
Manmeet Ahluwalia, MD, MBA, FASCO
Jakub Svoboda, MD
Suneel Kamath, MD
Ranee Mehra, MD
Jonathan Strosberg, MD
VK Gadi, MD, PhD
Komal Jhaveri, MD, FACP
Related Content
Bradley A. McGregor, MD
October 31st 2023

Sacituzumab Govitecan Plus Enfortumab Vedotin Shows Early Promise in Metastatic Urothelial Carcinoma

David Planchard, MD, PhD
October 27th 2023

Exploratory Analyses Show Trastuzumab Deruxtecan Elicits Consistent Intracranial Responses in HER2-Mutated NSCLC With Brain Metastases

Luis Paz-Ares, MD, PhD
October 26th 2023

Datopotamab Deruxtecan Elicits Antitumor Activity in Pretreated NSCLC With Actionable Genomic Alterations

Andrea Necchi, MD
October 24th 2023

TAR-200 Monotherapy Is Effective and Well Tolerated in BCG-unresponsive NMIBC

Antonio Passaro, MD, PhD
October 23rd 2023

Amivantamab With or Without Lazertinib Extends PFS in EGFR+ Advanced NSCLC After Progression on Osimertinib

Aaron Lisberg, MD
October 23rd 2023

Dato-DXd Significantly Improves PFS in Select Subsets of Advanced/Metastatic NSCLC